Background Selecting appropriate controls for studies of genetic variation in case series is important. The two major candidates involve the use of blood donors or a random sample of the population.
Results
The study subjects who had been blood donors differed markedly from the general population in social, health-related, anthropometric, and personality-related variables. Using theoretical examples, we show that blood donors are a poor control group for non-genetic studies of diseases related to environmentally, behaviourally, or socially patterned exposures. However, we show that if blood donors are used as controls in genetic studies, these factors are unlikely to make a major difference in detecting true associations with relatively rare disorders (cumulative incidence through life of <10%). Nevertheless, for more common disorders, the reduction in accuracy resulting from the inclusion in any control population of individuals who have or will develop the disease in question can create a greater bias than can socially patterned factors.
Introduction
Choice of the optimum control group is important for genetic, biochemical, or other assay-based association studies involving case collections of a particular disease. For example, at a time when case series may test 500 000 genetic variants and many thousands of values of data relating to gene-expression and/or metabolomic, epigenetic, or proteomic factors simultaneously, with the inherent cost of this, there is the temptation to use a multi-purpose set of controls so that, once typed, they can be compared with a variety of different case series. A technically easy option is to use blood donors. Many examples of the use of blood donors as controls in the study of genetic variants [1] [2] [3] and other blood markers [4] [5] [6] exist in the literature. However, in using blood donors as controls, it is tacitly assumed that blood donors are representative of the population from which are drawn the case series for which they are to serve as controls. We investigated the differences in a population of prospective parents enrolled between 1990 and 1992 in the Avon Longitudinal Study of Parents and Children (ALSPAC), a study designed to determine how interactions between genotypes and environmental factors influence health and development, to identify differences between those who had donated blood and those who had not.
In Britain, the published guidelines of 1989 for blood transfusion services in the United Kingdom 7 state that blood donors should appear healthy and range in age from 17-65 years; their medical history should be assessed to identify persons who should be permanently excluded (e.g. persons with circulatory disorders, drug allergy, diseases of the central nervous system, diseases of possible viral or autoimmune origin, chronic renal disease, and significant chest disease); among those to be temporarily excluded were persons who had recently had an infectious disease (for whom the time of exclusion varied from 2 years for infectious mononucleosis to the end of a course of antibiotic therapy for a sore throat), a minor or major accident (exclusion for 3-6 months), individuals taking most medications, and pregnant individuals (excluded until 1 year after delivery), among many others. The guidelines also specified that on presentation for blood donation, an individual's haemoglobin (Hb) level was to be measured and that women with an Hb <12.5 g/dL and men with an Hb <13.5 g/dL were to be excluded from blood donation. Individuals weighing <41 kg were also to be excluded.
Given such permanent and temporary exclusions, as well as confounding by other factors related to becoming a blood donor, it would be expected that blood donors would be less prone than average to infections, autoimmune diseases, asthma, and allergies to drugs, and would be less likely to be smokers. Additionally, women who had had a number of pregnancies would be less likely to be blood donors. In our study we assessed social, medical, and familial differences between persons who had and those who had not given blood.
Methods
ALSPAC began by enrolling pregnant women resident in Avon, UK, who were willing to take part in the study (an estimated 80-85% of the eligible population). 8 Criteria for eligibility were an expected date of delivery between 1 April 1991 and 31 December 1992. During pregnancy, prospective mothers in ALSPAC received a variety of different questionnaires that they completed in their own homes and posted back to the study headquarters. The information, although anonymised, has been linked to other information from the same mothers and their partners. The partners were contacted via the mothers, who were asked to invite them to take part in ALSPAC and to give them a questionnaire to complete if they were willing to do so. In all, 14 541 women completed at least one questionnaire, and more than 10 000 of their partners did so. 9 For the present analysis, we restricted the sample to those of white ethnicity aged 18 years and older.
Members of this study sample were asked, during pregnancy, whether they had ever donated blood, to which 29.4% of 12 350 mothers and 34.1% of the 8426 partners responded positively. Categorisation of parental education was based on the highest level of academic achievement (with five categories ranging from no education to a university degree or equivalent); social class of their current or most recent occupation (with five categories 10 ranging from I, for higher professional, to IV/V, for semi-skilled and unskilled manual); place of residence at the time of the respondent's birth [Avon (the study area) or not]; and parity (the number of previous pregnancies resulting in a live or still-birth).
Medical histories of the individuals in the study sample, and of their natural parents, were obtained through specific questions. 9 In addition, the individuals were asked for their perception of their own health (using a four-point scale with the categories of always well; usually well; sometimes unwell; often unwell). The women in the study sample were asked to make this assessment for the time before they became pregnant. The personality of each individual in the sample was assessed on the basis of the answers to 36 questions from the Boyce and Parker Interpersonal Sensitivity Scale 11 for the five domains of interpersonal awareness, need for approval, separation anxiety, timidity, and fragility of the inner self. An individual participant's height and weight (before pregnancy for prospective mothers) were those reported by the individual (a woman's reported height was more likely than a man's to be accurate because it would have been measured during her prenatal care).
Given the age limits on blood donation in the 1989 UK guidelines, and taking into account the probability that women who were 17 years old at delivery would have been too young to be donors or would already have been pregnant and therefore excluded from blood donation, we confined our analyses to persons aged 18 years and older. Only 4-5% of the individuals enrolled in the study were non-white. This group was less likely to have donated blood (16.8% of non-white women and 25.4% non-white men had ever donated blood, compared with 29.4% and 34.1% of white women and men respectively); the numbers were too small for valid analysis by the time the groups were split into specific ethnic minority groups. We therefore restricted our analysis to the white European population. In terms of our findings, this makes any differences between people who do and do not donate blood a conservative estimate, although many genetic epidemiology studies would also be likely to restrict cases and controls to members of a single ethnic group.
Statistical analyses
For unadjusted analyses, chi-square tests and logistic regression were used with categorical variables, and t-tests with continuous variables using SPSS v.12.0.1 (SPSS Inc., Chicago, IL, USA). Binomial probability tests using STATA v. 9.2 were employed to assess the number of values of P < 0.05 observed as compared with the number of such values expected if we assumed that the null hypotheses were valid. For these two groups (the 24 parental medical histories and the 52 associations with medical histories) we additionally used a cut-off value of P < 0.001. We did not do a correction for multiple testing because our analysis was conducted with the purpose of looking at the number of nominally statistically significant differences compared with the expected number, rather than identifying those factors that were least likely to have occurred by chance. Table 1 shows the prevalence of blood donation for both parent groups. There was a strong relationship 
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between blood donation and level of academic achievement, with a higher level of academic achievement correlating positively with a greater likelihood of ever having given blood. With regard to social class, parents in the manual semi-skilled (IV) and unskilled (V) groups were considerably less likely to have given blood than those in the non-manual groups. For women, increasing parity was inversely correlated with a likelihood of having previously given blood. However, parity was not associated with womens' partners' likelihood of having given blood. Parents who had been born in Avon (the study area) were much less likely to have given blood than those who had been born elsewhere but were currently resident in Avon. Table 2 compares anthropometric and personality measures of blood donors and non-donors. Individuals who were blood donors were on average taller and heavier than those who never donated. Personality traits also showed differences in mean scores for both sexes between those who had and had not given blood for interpersonal awareness, need for approval, timidity, and fragile inner self, although women showed a smaller effect size for each trait than did men (score differences of 0.28, 0.39, 0.34, and 0.12 vs. 0.91, 0.74, 0.69, and 0.39, respectively). In general, the more unwell the study participants rated themselves, the less likely they were to have donated blood (Table 3) . When analysed by medical condition (Appendix Table 1 ), women who had a history of eczema or allergies were slightly more likely to have given blood, as were men with a history of allergies, indigestion, and haemorrhoids. Both women and men were more likely to have given blood if they had less than perfect eyesight, as were men if they had poor hearing (data not shown). In contrast, a reduced likelihood of being a blood donor was evident for hay fever (women), epilepsy (both sexes), febrile convulsions (men only), migraine (women), kidney disease (women), drug addiction (both), and severe depression (women only). Men with alcoholism were also less likely to have given blood, but the numbers in this comparison were small. In all, of the 52 analyses, including the data on hearing, 18 (35%) were statistically significant at the conventional level of Table 2 ) 12 conditions were assessed: 10 (37%) were different at the 0.05 level including five (21%) at the 0.001 level. In contrast only 1.2 and 0.024 such differences, respectively, would have been expected by chance (P < 0.0001). Individuals were more likely to have given blood if their parents had a history of coronary heart disease (both men and women), arthritis (women), cancer (both), hypertension (both), and type II diabetes (women). Men were less likely to have given blood if a parent had a history of alcoholism.
Health factors
Hypothetical computation of likelihood of detecting real associations in case-control studies Having shown that the likelihood of an individual giving blood varied with the individual's background, medical history, and family history, we sought to assess the effect that this might have on case-control studies of the association of these variables with disease. Table 4 shows the numbers of study participants with a candidate genetic marker that one might expect under various assumptions. In each instance, 1000 cases of disease are compared with 1000 controls for 3 possible frequencies of genotype. The assumption throughout is that the true odds ratio (OR) of the disease being associated with the genotype is 2.0. We compared the performance of three types of controls according to a variety of hypothetical assumptions: (i) the optimal control (representative of the population but omitting the individuals who have had, currently have, or will ultimately have the disorder); (ii) a random group (representative of the general population); and (iii) blood donors.
Optimal controls
Assuming that the population of 1000 controls have not had, do not have, and never will have the disease for which a genotype association is being investigated, the numbers of controls who will have a genotype of frequency (f) 10%, 30%, and 50% will be 100, 300, and Assumes that of individuals with the history of the disease (in past, present or future), 40% will give blood but amongst those with no such history, only 20% will do so. f Assumes that of individuals with a history of the disease (in past, present or future), 20% will give blood but amongst those with no such history, 40% will do so. 
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This method of calculation gives the number of cases shown in the first line of Table 4 .
Random controls
and the OR is given by
where c is the number of cases with the genotype. With this method, the numbers of cases of each genotype and disease frequency in the random controls can be calculated. The results are shown in Table 4 . Note that for each genotype frequency the number of cases increases with the frequency of the disease in the population; conversely, the apparent OR falls with the frequency of disease. However for each disease frequency, the OR varies only marginally with genotype frequency.
It is unlikely that a genetic-association study based on a random control sample would be able to exclude controls who have, have had, or will have the disease for which the study is being conducted.
Blood donors as controls
For blood donors we examined two scenarios: (i) when more donors who have had or are destined to have the disease for which a genetic association study is being done give blood (40% vs. 20%); and (ii) when such individuals are less likely to donate blood (20% vs. 40%). Calculation of the number of cases involved will be similar to that used for the random controls described above. The results are compared in Table 4 .
Blood donors show larger than expected numbers of the genotype for which a disease-association study is being done if there is an increase in donations by individuals with the disease (e.g. with a gene frequency of 10% the numbers of affected controls increase from 115 to 154, with a corresponding reduction in ORs from 1.70 to 1.21). For the second scenario, in which the affected individuals are less likely to donate blood, the ORs become larger (from 1.52 to 1.90) as the number of donors with the disease decreases. Similar changes are shown with different frequencies of the genotype in non-affected individuals (Table 4) .
Controls biased demographically
If it is assumed that a disorder, K, is more prevalent in shorter individuals, and has prevalences of 4%, 3%, 2%, and 1% in the four quartiles of height in the general population, the case frequency of K will be 40%, 30%, 20%, and 10% of each quartile. Accordingly, in a population of 10 000 individuals, the numbers of those with the disease in the four height quartiles will be 4000, 3000, 2000, and 1000, respectively. Comparison of K with random controls should reveal this.
Suppose also that there is an important genetic variant that is related to height and is present in 30%, 24%, 18%, 12% of each height quartile. Then the case collection K of 10 000 individuals should include 2400 individuals (30% of 4000 þ 24% of 3000 þ 18% of 2000 þ 12% of 1000) ¼ (1200 þ 720 þ 360 þ 120) with the genetic variant.
This frequency, when compared with 2100 (30% of 2500 þ 24% of 2500 þ 18% of 2500 þ 12% of 2500) ¼ (750 þ 600 þ 450 þ 300) random controls, gives a true risk ratio of 1.14. However, with the strong bias among blood-donor controls towards taller individuals, there is little chance of showing the true effect. Conversely, if the true effect is null but the genetic trait under consideration is linked positively to height, the effect with blood donors will give erroneously significant results, whereas that with the random controls will give the true null effect.
Discussion
We believe that the present study is the first to attempt to define the differences between blood donors and non-donors using a large data set. Epidemiologists have long been aware of the need for appropriate controls for any study of cases, but this is often the most difficult aspect of study design. In studies comparing genetic or other blood markers, there is the added complexity of taking blood. It is therefore tempting to use, as controls, samples from blood donors that have been routinely collected, albeit for a different purpose. This strategy has been widely used for studies of genetic [1] [2] [3] as well as cytogenetic 12 and other blood [4] [5] [6] markers. In this study we compare individuals who have donated blood with those who have not within a population resident in Avon, UK, and who were willing to take part in a longitudinal cohort study. Although reasonably representative of the pregnant Avon population 9 in the early 1990s, the ALSPAC population does not include infertile individuals (whether voluntary or involuntary) or the older population. The study should therefore not be considered to provide a comprehensive view of biases among blood-donors.
Within the ALSPAC study, we have shown that adults who give blood differ in social class, cognitive ability (using educational achievement as a proxy), personality, anthropometry, their medical history and the medical histories of their parents. Our data are similar to those in the literature, showing differential uptake according to occupation 13 and higher levels of education. 14 As shown in other studies, proportionately fewer women give blood than men, and ethnic minorities tend to have a lower rate of blood donation than majority populations. Because criteria for blood donation vary across the world, different biases may occur. Unexpectedly, we found that individuals who were born and still resident in the study area were less likely to be blood donors than those who had moved into the area. If true nationally, this may have implications for genetic studies where matching is done by area.
There is some evidence that blood donors tend to have low self-esteem and give blood in order to improve their self-esteem. 15 We have been able to examine the personalities of the individuals who were blood donors, and have shown that they had different personality traits, particularly in regard to the 'Need for approval' scale, which reflects a wish to make others happy and to ensure that others will like and not reject them.
There is also a strong unexpected association of blood donation with a family history of several common chronic diseases (such as coronary heart disease) in which genetic factors are known to play a part. This bias in blood donors suggests that there are, or could be, more genotype differences between cases and controls than expected by chance. Few studies have compared genetic markers in different types of controls, and those studies that have done this were small and gave negative results. 16 The analysis of the Wellcome Trust Case Control Consortium compared 1500 controls from the 1958 British National Cohort Study with 1500 blood-donor controls using a genome wide array and showed very few differences between markers, although there were more significant outliers than would be expected by chance. 17 Thus, in general, the distribution of genetic variants among blood donors shows fewer differences with non-donors than is found for environmental factors.
Hypothetical calculations
The take-home messages from Table 4 are that when a real association exists:
(i) The frequency of a genotype in the non-affected population makes little difference in terms of the sizes of the ORs that will be demonstrated, whatever the control type. (ii) If a family history of the condition, the condition itself, or the candidate genotype are associated with an increased likelihood of the individual being a blood donor, the ORs that can be demonstrated will be reduced in comparisons with random controls, and vice versa. (iii) The ORs depend on the proportion of affected individuals included among the controls; consequently, the rarer a condition, the less impact control bias will have. (iv) For common disorders, ORs for associated genotypes are likely to be greatly underestimated.
Thus, we have shown in this hypothetical example that when the true OR of a genotype-related disease for cases as compared with controls is 2.0, the comparison with random or blood-donor controls approaches 2.0 only if the proportion of the population who have ever had or will get the disease is no more than 10%. Conversely, where there is no real association of a disease with a genetic variant (i.e. OR ¼ 1.00), the biases inherent in controls may produce a spurious relationship, although this will be of relatively small magnitude (data not shown).
Obviously the ideal design for a case-control study (i.e. the selection of optimal controls) is not generally feasible unless historic controls are used, with full details of their medical histories until the time of death, so that individuals with the disorder being examined in the study can be excluded. Even with this, however, one would have to take into account that individuals dying early may have developed the disease had they survived, and the same exclusion would have to have been likely in the case series (i.e. individuals would have died before becoming cases of the disease). One way around this involves the definition of a 'case' by using the diagnosis of a disease within a specific age window, in which instance the control sample can validly consist of individuals in whom the diagnosis was not made within that window.
From the general computations shown here, it is clear that both random and blood-donor controls can be suitable for detecting real associations of genotypes with relatively rare disorders (e.g. schizophrenia or Hodgkin's lymphoma) for which an onset before middle age ensures that a population of 50-year-old persons, for example, would not be likely to develop the disorder in the future. These controls may not be satisfactory for particularly common disorders, especially those of later onset (e.g. hypertension, type II diabetes) unless there is information on the individuals' family history of the disorder together with their own medical history. Exclusion of such individuals would allow more accurate estimation of true genetic effects, even though some of the individuals without a family history of the disorder may develop the disorder in the future. For rarer disorders there is no serious problem with controls selected in such a way that these exclusions cannot be made.
Choice of controls should ideally be based on the rule that they should be chosen from the same population as the cases, the only distinguishing feature being 'caseness' (in whatever way that is defined and ascertained). The case series that have been developed, however, often do not have any coherent definition of the baseline population from which the cases have been selected, nor how representative of the disorder the cases are in general. Thus there may be major biases both in the individual cases as well as in their controls.
From these considerations we believe that the key message emanating from our study is that control samples chosen as representative of the population may not be appropriate as comparison populations for common diseases unless they include information that will allow the exclusion of individuals who have developed or will develop the disease. There are also likely to be biases among cases that differ substantially from the biases within a control sample. Consequently, control populations without such basic data will generally not be appropriate for the study of social, behavioural, and environmental exposures or for the study of gene-by-environment interactions, or, indeed, for studies of DNA methylation status where the environment is known to have strong effects. 18 A powerful design would select cases and controls enrolled in the same (prospective) study. This would be feasible in large studies, such as the UK Biobank study. 19 However, other issues, such as the late average age of onset of cases in such cohorts, and the often lower genetic contribution to disease risk at older ages, the long time lag to onset, and the high costs involved need to be considered. For smaller detailed studies (e.g. the 1958 cohort), 20 the duration of follow up, the accuracy of data, and the study of relevant traits within the population will be likely to provide as much (or more) information of value for common diseases, and especially for quantitative disease traits. It is tempting to use control samples stripped of personal information, since this overcomes the challenging and costly issue of protecting confidentiality, but this may be a false economy in the study of some aspects of common disease aetiology.
Funding
Collection of the data used in this paper was funded by a variety of contributors including UK Government departments, charities and research councils amongst others. The UK Medical Research Council, the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. 
